Market Overview

Roth Capital Downgraded RTI Biologics, Inc. to Neutral, Raised PT to $5.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for RTIX

DateFirmActionFromTo
May 2015Sidoti & Co.Initiates Coverage onBuy
Oct 2014Canaccord GenuityMaintainsBuy
Sep 2014JMP SecuritiesMaintainsMarket Outperform

View More Analyst Ratings for RTIX
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (RTIX)

Around the Web, We're Loving...